Cartherics appoints new Chief Scientific Officer
By Christine Filippis / October 17, 2023
Melbourne, Australia, 17 October 2023 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for...
Read More
Ovarian cancer is not ovarian cancer
By Christine Filippis / October 3, 2023
Cartherics’ Dr Ian Nisbet (Chief Operating Officer) and Kathy Skoff (Clinical Trials Manager) recently attended an ovarian cancer symposium in...
Read More
Combining new and existing immunity: a 3D approach to killing cancer
By Christine Filippis / September 25, 2023
by Richard Boyd and Aleta Pupovac A question which has long baffled scientists, frustrated clinicians and devastated patients is why...
Read More
Heather Hawkins Ovarian Cancer Journey
By Christine Filippis / August 24, 2023
Heather Hawkins, Cartherics Board Advisor and patient advocate, shares her personal journey with ovarian cancer in the hope that it...
Read More
Bio Connections Australia 2023 promotes science commercialisation
By Christine Filippis / July 31, 2023
Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world...
Read More
Australia – China Science and Innovation Forum fosters collaboration and commercialisation
By Christine Filippis / June 28, 2023
The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum...
Read More
Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development
By Christine Filippis / June 16, 2023
Cartherics’ Acting Chief Scientific Officer, Dr Walid Azar recently attended the 2nd Cell Therapy Potency Assay Summit in Boston. The...
Read More
Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents
By Christine Filippis / May 30, 2023
Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in...
Read More
Cartherics to present at the 2023 BIO International Convention
By Christine Filippis / May 24, 2023
Melbourne, Australia, 24 May 2023 – Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of...
Read More
Cartherics congratulates Rasa Islam on PhD success
By Christine Filippis / May 16, 2023
Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature. Rasa’s research thesis, titled, Re-engineering the...
Read More
Cartherics to present at the CIMT Annual Meeting in Germany
By Christine Filippis / May 2, 2023
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th...
Read More
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China
By Christine Filippis / April 28, 2023
Melbourne, Australia, 28 April 2023 – Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment...
Read More
Cartherics’ offsite provides the opportunity to connect, engage and grow
By Christine Filippis / April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More
Cartherics proudly supports the White Shirt Campaign
By Christine Filippis / April 11, 2023
Cartherics is hosting a White Shirt Day lunch on 8th May to help raise funds and awareness for ovarian cancer....
Read More
Cartherics to present at ThymOz 2023
By Christine Filippis / March 22, 2023
Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March...
Read More
